chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.7
Sex: F
Vaccine: DTAP, PNC
Symptoms: Rash
Clinical narrative: A territory representative reported that an 8 month old female received Prevnar and Acel-Imune vaccines on 8/29/00. On 9/2/00, she developed a generalized rash. She was treated with oral diphenhydramine and recovered.
Age: 1.5
Sex: F
Vaccine: DTAP, IPV, PNC
Symptoms: Injection site swelling
Clinical narrative: A physician reported that an 18 month old female received Prevnar, IPV and Infanrix vaccines on 9/8/00. On 9/9/00, she developed a "golf ball-sized" area of swelling at the site of the Prevnar injection. She was seen by the physician, who prescribed cold compresses and acetaminophen. She recovered.
Age: 1.25
Sex: M
Vaccine: HIBV, IPV, PNC
Symptoms: Urticaria
Clinical narrative: A physician reported that a 15 month old male received Prevnar, IPV and Hib-Titer vaccines on 9/11/00. Within 2 hours, he developed hives. He was seen by the physician and treated with diphenhydramine. He recovered within 3 hours.
Sex: U
Vaccine: PNC
Symptoms: Hypersensitivity, Rash
Clinical narrative: A physician reported that a pt received an injection of Prevnar and subsequently developed a rash. The pt was taking amoxicillin at the time. The reporter noted that this event was a "possible allergic reaction". No further information was available at the date of this report.
Sex: U
Vaccine: PNC
Symptoms: Rash
Clinical narrative: A pediatrician reported that a child received an injection of Prevnar. Approx. 24 to 48 hours, post vax, the child developed a "non-hive" rash. No further information was available at the date of this report. The reporter indicated that 5 or 6 pts experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided.
Age: 0.5
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Rash
Clinical narrative: A territory representative reported that a 6 month old male received his 1st dose of Prevnar, as well as, Tripedia and Act-Hib vaccines on 9/18/00. On 9/19/00, the infant developed rash described as looking "almost like prickly heat or roseola".
Sex: U
Vaccine: PNC
Symptoms: Injection site pain
Clinical narrative: A physician reported that children experienced pain during the administration of Prevnar. The physician stated that more pain is experienced during Prevnar administration compared to other vaccines. No further information was available at the date of this report. The reporter was unable to specify the number of pts who experienced this event. Additional reports will be generated when identifying information is provided.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Anorexia, Irritability, Pyrexia
Clinical narrative: Subsequent to receiving vax, the pt developed a fever, irritability and fussiness. The mother reported that the pt would not take his bottle. He was treated with Tylenol. The fever resolved in 24 hours. A copy of this report was forwarded to Aventis Pasteur and Merck, Sharp & Dome, manufacturers of the concomitantly administered vaccines.
Sex: U
Vaccine: PNC
Symptoms: Pyrexia
Clinical narrative: Subsequent to receiving vax, the pt developed a fever of 102 degrees. The reporter indicated that 2 pts experienced fever; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided.
Age: 0.5
Sex: M
Vaccine: DTAP, HEP, HIBV, PNC
Symptoms: Pyrexia
Clinical narrative: Subsequent to receiving vax, the pt developed a fever of 103 degrees which lasted 8 hours. Additional information received from the reporter provided lot numbers and number of previous doses received for the concomitantly administered vaccines. The pt remained recovered.
Age: 1.25
Sex: M
Vaccine: HIBV, MMR, PNC
Symptoms: Pyrexia, Vomiting
Clinical narrative: Subsequent to receiving vax, the pt developed a fever of 102.3F and had one large vomiting episode. The fever persisted as of 09/28/2000. A copy of this report has forwarded to Merck, manufacturer of MMR.
Sex: U
Vaccine: PNC
Symptoms: Rash
Clinical narrative: Subsequent to receiving vax, the pt developed a body rash. The reporter indicated that the rash resolved spontaneously. This is 1 of 3 pts who had an adverse experience following receipt of Prevnar.
Age: 1.6
Sex: F
Vaccine: PNC
Symptoms: Pyrexia
Clinical narrative: Within 24 hours post vax, the pt developed a fever of up to 100.5 degrees F. The reporter indicated that as of 09//, the child's fever rose to 102.2 degrees F.
Sex: U
Vaccine: PNC
Symptoms: Injection site warmth
Clinical narrative: Subsequent to receiving vax, the pt developed warmth at the injection site. No further information was available at the date of this report.
Age: 0.2
Sex: U
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Pyrexia
Clinical narrative: Four to five days post vax, the pt developed a fever which rose to 102 degrees and resolved within 24 hours. The reporter indicated that 4 infants experienced this event; however, they are not presently identifiable. Additional information received from the vaccine provider stated that the infant was given a complete physical within 24 hours of the event. Concomitant vaccines included DTaP, Hib, and IPV. The pt remained recovered. The reporter stated that the office was unable to provide identifying information for the other pts.
Sex: U
Vaccine: PNC
Symptoms: Pyrexia
Clinical narrative: One day post vax, the pt developed a high fever. The reporter indicated that 2 to 3 children experienced this event; however, they are not presently identifiable. Additional reports will be generated when identifying information is provided.
Sex: U
Vaccine: DTP, HIBV, IPV, PNC
Symptoms: Rash, Urticaria
Clinical narrative: Seven days post vax, the pt developed a rash (hives). A copy of this report has been forwarded to Aventis Pasteur, manufacturer of IPV.
Age: 4.0
Sex: M
Vaccine: PNC
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Injection site pain, Otitis media
Clinical narrative: Subsequent to receiving vax, the pt developed an injection site reaction characterized by very large circular area 1.5 - 2 inches, of redness, hardness, swelling and pain. From 3-5 days post vax, the injection site redness slowly dissipated, the swelling went down and the hardness resolved. At the time of immunization, the child was diagnosed with recurrent acute otitis media. After 7 days the injection site pain resolved, the pt recovered.
Age: 1.3
Sex: M
Vaccine: HIBV, MMR, PNC
Symptoms: Decreased appetite, Ear disorder, Infection, Somnolence
Clinical narrative: One day post vax, the pt became very sleepy and had a decreased appetite. Four days post vax, the pt developed an ear infection. The pt was treated with Ceftin.
Sex: U
Vaccine: PNC
Symptoms: Injection site reaction
Clinical narrative: Subsequent to receiving vax, the pt developed a local reaction. No further information was available at the date of this report. The reporter was unable to specify the number of pts who experienced this event. Additional reports will be generated when identifying information is provided
Sex: F
Vaccine: PNC
Symptoms: Injection site mass
Clinical narrative: One day post vax, the pt developed a knot at the injection site. No further information was available at the date of this report.
Sex: U
Vaccine: PNC
Symptoms: Injection site mass
Clinical narrative: One day post vax, the pt developed a skin knot at the injection site. No further information was available at the date of this report.
Age: 0.08
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Oedema peripheral
Clinical narrative: Subsequent to receiving vax, the pt developed severe swelling in the left leg that extended from the knee to the groin. Prevnar and ProHIBit were both injected into the left leg. A copy of this report has been forwarded to Aventis Pasteur, manufacturer of ProHIBit.
Sex: U
Vaccine: PNC
Symptoms: Pneumonia, Pyrexia
Clinical narrative: Subsequent to receiving vax, the pt developed a fever. A few days post vax the pt was diagnosed with pneumonia. The pt was treated with Zithromax. No further information was available at the date of this report.
Age: 0.6
Sex: M
Vaccine: IPV, PNC
Symptoms: Urticaria
Clinical narrative: subsequent to receiving vax, the pt developed hives. A copy of this report has been forwarded to Aventis Pasteur, manufacturer of IPV.
Age: 1.5
Sex: F
Vaccine: PNC
Symptoms: Pyrexia
Clinical narrative: Physician reported that patient received vaccination on 10/19/00 and that same day developed a fever "up to 105 deg. F". She was treated with Tylenol (acetaminophen).
Age: 0.25
Sex: M
Vaccine: PNC
Symptoms: Pyrexia, Rash
Clinical narrative: A territory representative reported that the patient received the vaccination and subsequently developed a fever which resolved within 1.5 weeks. He then developed a rash which spread over his entire body. Additional information received from the physician on 12/22/2000 indicated that the rash resolved.
Age: 0.6
Sex: F
Vaccine: DTAP, PNC
Symptoms: Bronchiolitis, Cough, Otitis media, Wheezing
Clinical narrative: Mother, who is also a nurse, reported that her daughter received her first dose of Prevnar as well as Tripedia (Aventis Pasteur) on 10/27/2000 and 12 to 24 hours later, developed bronchiolitis with a "raspy" cough. She has a recent medical history (approximately 3 weeks ago) of RSV with a "raspy" cough, fever of 103 deg. F and "double" ear infections. The fever resolved 3 days later. She was treated with antibiotics and had been symptom-free for approximately 10 days prior to immunization. Follow up information received 12/28/2000 from the physician indicated the patient received Prevnar and Tripedia on 10/25/2000. On 10/30/2000 the patient experienced wheezing. Fifteen days later she was seen by the physician and a diagnosis of otitis media was made. The patient was prescribed an antibiotic. The patient was seen by the physician again on 11/28/2000 and had recovered. The physician indicated that these events were unrelated to the vaccine administration.
Age: 1.0
Sex: M
Vaccine: HBHEPB, PNC, VARCEL, HBHEPB, PNC, VARCEL
Symptoms: Vomiting
Clinical narrative: Physician reported that patient received Prevnar, Comvax (Merck), and Varivax (Merck) on 11/01/00. Within 12 hours post immunization, he developed vomiting. The physician indicated that as of 11/05/00, the patient has vomited once each day since vaccination. This is 1 of 3 children from this facility who has had an adverse experience following receipt of Prevnar. Additional information received 12/29/2000 indicated the patient recovered.
Age: 0.25
Sex: F
Vaccine: HEP, PNC
Symptoms: Injection site erythema, Injection site inflammation, Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: The mother, who is a healthcare professional, reported that the patient received Prevnar and Recombivax-HB (Merck) on 11/10/00. That evening she developed redness, swelling, and inflammation that presented as a "big ball" at the injection site. Touching the site caused the child to cry. She was treated with cold compresses and acetaminophen. On 11/11/00, the redness resolved. As of 11/13/00, the "big ball" was still present.
Sex: U
Vaccine: PNC
Symptoms: Diarrhoea
Clinical narrative: A physician reported that a patient received a Prevnar vaccine and 4 to 10 days later developed diarrhea.
Age: 0.5
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Ear disorder, Infection, Pyrexia, Vomiting
Clinical narrative: Mother reported that the patient received her first dose of Prevnar along with IPV (Aventis Pasteur SA), DTaP (manufacturer unknown), and Hib (manufacturer unknown) on 09/06/00 and subsequently developed a fever of 101.8 deg. F. and vomiting. One or two days post-immunization, she developed an ear infection. She was treated with either azithromycin or amoxicillin.
Age: 2.0
Sex: F
Vaccine: PNC
Symptoms: Urticaria
Clinical narrative: A territory representative reported that a patient received a Prevnar vaccine and subsequently developed hives. The patient was treated with diphenhydramine and recovered within 24 to 48 hours. No further information was available at the date of this report. Additional information received on 01/04/2001 from the physician indicated the patient, a 2-year-old female, received the Prevnar injection on 11/20/2000. The adverse experience occurred 4 hours post-immunization.
Age: 2.0
Sex: F
Vaccine: PNC
Symptoms: Pyrexia
Clinical narrative: Physician reported that patient received a Prevnar vaccine on 9/20/2000, and on 9/24/2000 she developed a fever of greater than 102 deg. F. The patient recovered. This is 1 of 5 patients from this facility who experienced this event following receipt of 3 different lots of Prevnar.
Age: 0.5
Sex: F
Vaccine: DTP, HIBV, PNC
Symptoms: Pyrexia
Clinical narrative: Physician reported that patient received Prevnar, Hib-Titer, and DPT (manufacturer unknown) on 8/19/2000. The next day the patient developed a fever of greater than 102 deg. F. This is 1 of 5 patients from this facility who experienced this event following receipt of 3 different lots of Prevnar.
Age: 0.75
Sex: M
Vaccine: HEP, IPV, PNC
Symptoms: Pyrexia
Clinical narrative: Physician reported that patient received Prevnar, IPV (Aventis Pasteur SA), and hepatitis B vaccines on 9/19/2000. The next day the patient developed a fever of greater than 102 deg. F. He recovered. This is 1 of 5 patients from this facility who experienced this event following receipt of 3 different lots of Prevnar.
Age: 1.08
Sex: M
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Pyrexia
Clinical narrative: Physician reported that patient received Prevnar, haemophilus B (manufacturer unknown), measles, mumps, rubella (manufacturer unknown), and varicella virus (manufacturer unknown) vaccines on 9/15/2000. On 9/18/2000 the patient developed a fever of greater than 102 deg. F. He recovered. This is 1 of 5 patients from this facility who experienced this event following receipt of 3 different lots of Prevnar.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Diarrhoea, Injection site erythema, Injection site oedema, Injection site warmth, Vomiting
Clinical narrative: Physician reported that patient received Prevnar, Acel-Imune, Hib-Titer, and IPV (Aventis Pasteur SA) on 8/21/2000. Within 24 hours post-immunization, she developed vomiting and diarrhea. She also developed redness, swelling, and warmth at an unspecified injection site. The vomiting and diarrhea resolved after 2 to 3 days.
Age: 0.75
Sex: F
Vaccine: PNC
Symptoms: Vomiting
Clinical narrative: Physician reported that patient received a Prevnar vaccine on 11/03/2000, and five hours post-immunization, she developed vomiting. The event lasted 24 hours. The patient recovered. This is 1 of 3 patients from this facility who had an adverse experience following receipt of Prevnar.
Age: 1.75
Sex: M
Vaccine: MMR
Symptoms: Abnormal behaviour, Autism, Speech disorder
Clinical narrative: Autistic child: difficult infant who did not develope age appropriate speed. He was referred for evaluation at 2 years of age with ultimate dx of autism. Physician feels speech not present early and temporal association with vaccine. 60 day follow-up states the event was not due to vaccine.
Age: 0.8
Sex: F
Vaccine: DTAP
Symptoms: Diarrhoea, Haemolysis, Hypotonia, Pyrexia, Stupor
Clinical narrative: Hyporesponsive, hypotonic reactions with vomiting, fever and diarrhea that occurred acutely, 8 hours, post vax of DTAP. Called 911; because could not arouse and brought to ER.
Age: 0.8
Sex: F
Vaccine: DTAP
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: Hyporesponsive, hypotonic reactions with vomiting, fever and diarrhea that occurred acutely, 8 hours, post vax of DTAP. Called 911; because could not arouse and brought to ER.
Age: 36.0
Sex: M
Vaccine: LYME
Symptoms: Antinuclear antibody positive, Arthralgia, Borrelia burgdorferi serology negative, Burning sensation, C-reactive protein normal
Clinical narrative: Shortly after receiving 1st of 3 shots, started experiencing sharp pain in right knee. After receiving 2nd shot, joint pain spread rapidly to left knee, feet, hands, left elbow and both hips. I have also experienced a constant burning and tingling sensation in both knees. Symptoms have been worsening over the past year and a half. I have lost considerable time from work and my personal life has been dramatically affected. I had no prior history of arthritis or any joint pain prior to receiving the Lymerix vaccine. Drugs that I have been treated with include Vioxx, indomethacin, Cortizone shot, hydroxychloroquine and prednisone thus far. None of these drugs, with exception of prednisone, have done much for the pain, discomfort and loss of mobility. I am currently seeking treatment for relief from the affects of the vaccine with several doctors. Report 2001005977-1 described arthrilgia in a 37-year-old male who received LYMERIX. Concurrent medical conditions included prostatitis (1995) and gastroesophageal reflux disease. A diagnosis of hypertention was made sometime in the year 2000. The patient did not have gout, psoriasis, Crohn's disease, or Lyme disease. There was no family history of rhematoid arthritis, lupus erythematosus, or other rheumatological disorders. There was no illness at the time of immunization. There were no concurrent medications. The paitent received his first injection of LYMERIX on 10 May 1999 at his place of employment. On 16 June 1999, he experienced arthralgia of the fingers, the toes, and both knees. The paitent received his second injection of LYMERIX on 17 June 1999. The patient was seen by a rheumatologist, an orthodedist, and an infectious disease specialist. No evidence of arthritis was found. He was treated with 10 to 15 mg of PREDNISONE daily, beginning on an uspecified day in June 2000. At the time the reporting physician examined the patient, the patient was taking PREDNISONE. No overt joint swelling, erythema, or warmth was observed by the reporting physician, No joint fluid was obtained. On 20 February 2001, RF, ESR, and CRP were nomral. Rapid plasmin reagin, antistreptolysin O titer, Lyme serlolgy, and Lyme Western blot were negative. Antinuclear antibody titer was positve at 1:80. The LYMERIX administration immunization series was stopped. The most recent information was received from the infectious desease specialist on 16 April 2001. This physician considered the arthralgia to be moderate in intesity and possibly related to LYMERIX administration. The arthralgia presisted as of 13 March 2001. As of 28 March 2001, the patient's serlogies have continued to remain negative. The adverse event of arthralgia does not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the June 28, 2000 letter.
Age: 36.0
Sex: M
Vaccine: LYME
Symptoms: Hypertension, Hypokinesia, Immunology test, Impaired work ability, Paraesthesia
Clinical narrative: Shortly after receiving 1st of 3 shots, started experiencing sharp pain in right knee. After receiving 2nd shot, joint pain spread rapidly to left knee, feet, hands, left elbow and both hips. I have also experienced a constant burning and tingling sensation in both knees. Symptoms have been worsening over the past year and a half. I have lost considerable time from work and my personal life has been dramatically affected. I had no prior history of arthritis or any joint pain prior to receiving the Lymerix vaccine. Drugs that I have been treated with include Vioxx, indomethacin, Cortizone shot, hydroxychloroquine and prednisone thus far. None of these drugs, with exception of prednisone, have done much for the pain, discomfort and loss of mobility. I am currently seeking treatment for relief from the affects of the vaccine with several doctors. Report 2001005977-1 described arthrilgia in a 37-year-old male who received LYMERIX. Concurrent medical conditions included prostatitis (1995) and gastroesophageal reflux disease. A diagnosis of hypertention was made sometime in the year 2000. The patient did not have gout, psoriasis, Crohn's disease, or Lyme disease. There was no family history of rhematoid arthritis, lupus erythematosus, or other rheumatological disorders. There was no illness at the time of immunization. There were no concurrent medications. The paitent received his first injection of LYMERIX on 10 May 1999 at his place of employment. On 16 June 1999, he experienced arthralgia of the fingers, the toes, and both knees. The paitent received his second injection of LYMERIX on 17 June 1999. The patient was seen by a rheumatologist, an orthodedist, and an infectious disease specialist. No evidence of arthritis was found. He was treated with 10 to 15 mg of PREDNISONE daily, beginning on an uspecified day in June 2000. At the time the reporting physician examined the patient, the patient was taking PREDNISONE. No overt joint swelling, erythema, or warmth was observed by the reporting physician, No joint fluid was obtained. On 20 February 2001, RF, ESR, and CRP were nomral. Rapid plasmin reagin, antistreptolysin O titer, Lyme serlolgy, and Lyme Western blot were negative. Antinuclear antibody titer was positve at 1:80. The LYMERIX administration immunization series was stopped. The most recent information was received from the infectious desease specialist on 16 April 2001. This physician considered the arthralgia to be moderate in intesity and possibly related to LYMERIX administration. The arthralgia presisted as of 13 March 2001. As of 28 March 2001, the patient's serlogies have continued to remain negative. The adverse event of arthralgia does not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the June 28, 2000 letter.
Age: 36.0
Sex: M
Vaccine: LYME
Symptoms: Red blood cell sedimentation rate normal, Rheumatoid factor negative, Syphilis test negative
Clinical narrative: Shortly after receiving 1st of 3 shots, started experiencing sharp pain in right knee. After receiving 2nd shot, joint pain spread rapidly to left knee, feet, hands, left elbow and both hips. I have also experienced a constant burning and tingling sensation in both knees. Symptoms have been worsening over the past year and a half. I have lost considerable time from work and my personal life has been dramatically affected. I had no prior history of arthritis or any joint pain prior to receiving the Lymerix vaccine. Drugs that I have been treated with include Vioxx, indomethacin, Cortizone shot, hydroxychloroquine and prednisone thus far. None of these drugs, with exception of prednisone, have done much for the pain, discomfort and loss of mobility. I am currently seeking treatment for relief from the affects of the vaccine with several doctors. Report 2001005977-1 described arthrilgia in a 37-year-old male who received LYMERIX. Concurrent medical conditions included prostatitis (1995) and gastroesophageal reflux disease. A diagnosis of hypertention was made sometime in the year 2000. The patient did not have gout, psoriasis, Crohn's disease, or Lyme disease. There was no family history of rhematoid arthritis, lupus erythematosus, or other rheumatological disorders. There was no illness at the time of immunization. There were no concurrent medications. The paitent received his first injection of LYMERIX on 10 May 1999 at his place of employment. On 16 June 1999, he experienced arthralgia of the fingers, the toes, and both knees. The paitent received his second injection of LYMERIX on 17 June 1999. The patient was seen by a rheumatologist, an orthodedist, and an infectious disease specialist. No evidence of arthritis was found. He was treated with 10 to 15 mg of PREDNISONE daily, beginning on an uspecified day in June 2000. At the time the reporting physician examined the patient, the patient was taking PREDNISONE. No overt joint swelling, erythema, or warmth was observed by the reporting physician, No joint fluid was obtained. On 20 February 2001, RF, ESR, and CRP were nomral. Rapid plasmin reagin, antistreptolysin O titer, Lyme serlolgy, and Lyme Western blot were negative. Antinuclear antibody titer was positve at 1:80. The LYMERIX administration immunization series was stopped. The most recent information was received from the infectious desease specialist on 16 April 2001. This physician considered the arthralgia to be moderate in intesity and possibly related to LYMERIX administration. The arthralgia presisted as of 13 March 2001. As of 28 March 2001, the patient's serlogies have continued to remain negative. The adverse event of arthralgia does not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the June 28, 2000 letter.
Sex: U
Vaccine: FLU3
Symptoms: Influenza like illness
Clinical narrative: A territory representative reported that a pt received an injection and subsequently developed flu-like symptoms. The pt was hospitalized. The reporter indicated that 11 pts experienced this event however they are not presently identifiable. Additional reports will be generated when identifying information is provided.
Age: 60.0
Sex: F
Vaccine: LYME
Symptoms: Abdominal pain upper, Anaemia, Arthralgia, Eye pain, Fatigue
Clinical narrative: Pt experienced severe fatigue, tingling through body, muscle pain, joint pain, rapid heart beat, anemia, stomach pain, pressure in head and eyes, sore throat, numbness in jaw and nose area, and was sick for 8 months before finally being treated with doxycycline.
Age: 60.0
Sex: F
Vaccine: LYME
Symptoms: Headache, Heart rate increased, Hypoaesthesia, Malaise, Myalgia
Clinical narrative: Pt experienced severe fatigue, tingling through body, muscle pain, joint pain, rapid heart beat, anemia, stomach pain, pressure in head and eyes, sore throat, numbness in jaw and nose area, and was sick for 8 months before finally being treated with doxycycline.
Age: 60.0
Sex: F
Vaccine: LYME
Symptoms: Paraesthesia, Pharyngolaryngeal pain
Clinical narrative: Pt experienced severe fatigue, tingling through body, muscle pain, joint pain, rapid heart beat, anemia, stomach pain, pressure in head and eyes, sore throat, numbness in jaw and nose area, and was sick for 8 months before finally being treated with doxycycline.
Age: 39.0
Sex: F
Vaccine: LYME, TD
Symptoms: Arthritis, Back pain, Depression, Fibromyalgia, Headache
Clinical narrative: Pt experienced headaches, depression, multi-system problems, pain in muscles and tendons within three days post vax.  Pt also developed arthritis in right shoulder, knee and hips, increased fibromyalgia, back, neck and body pain.
Age: 39.0
Sex: F
Vaccine: LYME, TD
Symptoms: Myalgia, Neck pain, Pain
Clinical narrative: Pt experienced headaches, depression, multi-system problems, pain in muscles and tendons within three days post vax.  Pt also developed arthritis in right shoulder, knee and hips, increased fibromyalgia, back, neck and body pain.
Age: 39.0
Sex: F
Vaccine: LYME, TD
Symptoms: Arthritis, Depression, Fibromyalgia, Headache, Myalgia
Clinical narrative: Pt experienced headaches, depression, multi-system problems, pain in muscles and tendons within three days post vax.  Pt also developed arthritis in right shoulder, knee and hips, increased fibromyalgia, back, neck and body pain.
Age: 39.0
Sex: F
Vaccine: LYME, TD
Symptoms: Pain
Clinical narrative: Pt experienced headaches, depression, multi-system problems, pain in muscles and tendons within three days post vax.  Pt also developed arthritis in right shoulder, knee and hips, increased fibromyalgia, back, neck and body pain.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR, PNC
Symptoms: Pyrexia, Rash macular
Clinical narrative: Subsequent to receiving vax, the pt developed a fever of up to 101. Five days post vax, the pt developed a fine imprint macular rash on neck and trunk.
Age: 2.0
Sex: F
Vaccine: PNC
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Pt developed redness/edema at injection site noted within 24 hours post vax. (1.5 X .75 inch area) Pt was treated with Benadryl, analgesics and warm compress.
Age: 0.9
Sex: M
Vaccine: DTP, HBHEPB, IPV, PNC
Symptoms: Agitation, Pyrexia, Vomiting
Clinical narrative: Pt developed a fever of 102, vomiting and crying inconsolably. Injection site clear. The pt recovered later that day, fever subsided, no longer crying and no vomiting.
Age: 3.0
Sex: F
Vaccine: HEPA, PNC
Symptoms: Cough, Nasal congestion, Pyrexia
Clinical narrative: Subsequent to receiving vax, the pt developed a cough with a fever of 100 degrees. One day post vax the pts fever was up to 103.8. Two days post vax the pts fever rose to 105.4 and was accompanied by a stuffy nose. Pt had a normal exam and normal urine sample.
Age: 1.5
Sex: F
Vaccine: PNC
Symptoms: Urticaria
Clinical narrative: One day post vax, the pt developed urticarial rash. Pt otherwise stable.
Age: 1.08
Sex: F
Vaccine: IPV, MMR, PNC, VARCEL
Symptoms: Conjunctivitis, Cough, Decreased appetite, Irritability, Pharyngitis
Clinical narrative: Eight days post vax, the pt developed a fever to 101 that lasted for three days. Pt also developed a cough, conjunctivitis maculopapular rash to torso, pharyngitis, decreased appetite and irritability. Illness appeared consistent with measle like illness. Pt still symptomatic 13 days post vax.
Age: 1.08
Sex: F
Vaccine: IPV, MMR, PNC, VARCEL
Symptoms: Pyrexia, Rash maculo-papular
Clinical narrative: Eight days post vax, the pt developed a fever to 101 that lasted for three days. Pt also developed a cough, conjunctivitis maculopapular rash to torso, pharyngitis, decreased appetite and irritability. Illness appeared consistent with measle like illness. Pt still symptomatic 13 days post vax.
Sex: M
Vaccine: DTAP, PNC
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Pt experienced swelling/erythema of greater than 50% of left thigh.
Age: 1.6
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Injection site reaction
Clinical narrative: Pt experienced a local reaction at the injection site.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Blister, Erythema, Pyrexia
Clinical narrative: Pt presented with multiple fine point red vesicles in various stages on cheeks, arms, back, trunk, and legs. Temperature up to 104.5.
Age: 1.8
Sex: U
Vaccine: DT, HIBV, MMR, PNC, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Within 11 days post vax the pt developed a fever and a non-pruritic rash from the face down.
Age: 1.0
Sex: M
Vaccine: HBHEPB, IPV, MMR, PNC, VARCEL
Symptoms: Infection
Clinical narrative: With one day post vax, the pt developed a mild case of chickenpox.
Age: 0.5
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Injection site reaction
Clinical narrative: Pt experienced a localized reaction.
Age: 0.3
Sex: M
Vaccine: DT, HIBV, IPV, PNC
Symptoms: Irritability, Pyrexia
Clinical narrative: On 1/9/01 the pt was irritable and experienced a fever of 102. Seen in office. On 1/10/01 was seen in the ER.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Pt developed extensive hives all over body, was relieved with diphenhydramine.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site haemorrhage, Injection site pain, Myalgia
Clinical narrative: Pt experienced bruising at injection site for two weeks post vax. Pts arm is continuously sore at the site and the muscles ache constantly. Area is very sore.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Anorexia, Constipation, Ear discomfort, Joint swelling, Nasal congestion
Clinical narrative: Pt experienced a sore neck for 10 days; chills/fever and congestion for 3 days; both wrists and knees were sore a swollen for 3 days; soreness at the bottom of rib cage for 21 days; constipation and loss of appetite for 14 days; and ears were plugged up for 21 days.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Neck pain, Pyrexia
Clinical narrative: Pt experienced a sore neck for 10 days; chills/fever and congestion for 3 days; both wrists and knees were sore a swollen for 3 days; soreness at the bottom of rib cage for 21 days; constipation and loss of appetite for 14 days; and ears were plugged up for 21 days.
Age: 69.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Within one day post vax, the pts left upper arm was red, swollen and warm to the touch. By that afternoon it had spread to the forearm as well. Pt treated with Riaxin for 10 days.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Pt developed raised red bumps on face and trunk one day post vax that last for 10 days.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Hypokinesia, Pain
Clinical narrative: Pt reported experiencing difficulty lifting her left arm since receiving the vax. The arm is in a lot of pain.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Tongue disorder, Urticaria
Clinical narrative: Pt developed hives and a thick tongue.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Approximately 24 hours post vax the pt developed a fine red rash on both forearms from the elbows to the wrists, very itchy.  Pt was seen by physician and treated with Prednisone and Benadryl for 5 days. The rash subsided in about one week with no recurrence.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Facial palsy
Clinical narrative: Pt developed Bells Palsy. Treated with Prednisone.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Pt experienced pain radiating from right deltoid area.
Age: 44.0
Sex: F
Vaccine: HEPA
Symptoms: Eye irritation, Flushing, Headache, Pain
Clinical narrative: Within one hour post vax, the pt experienced head pressure, flushing of face, trunk and arms, upper body achiness, eye irritation without redness or drainage, and malaise.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Urticaria
Clinical narrative: Four hours post vax, the pt developed a raised, red wheal area with red edge at injection site that was warm to the touch. Pt instructed to treat with ice and Tylenol. Pt returned to office approximately 2 hours later with large 10 X 12 cm wheal on left upper extremity and injection site. Area remained warm to the touch. Pt denied any respiratory difficulty. Temperature 98 degrees, heart rate 62/min, BP 120/80. Pt treated with Atarax, Prednisone and cool compresses. Pt advised to seek urgent care if any SB, palatal swelling or other acute changes.
Age: 10.0
Sex: F
Vaccine: HEP, IPV, MMR
Symptoms: Eye movement disorder, Headache, Loss of consciousness, Muscle rigidity, Nausea
Clinical narrative: Immediately, post vax, the pt became rigid with her eyes rolled back in her head and loss of consciousness. She was lifted to the floor in RN's lap. Vital signs stable. Circumoral pallor. Ammonia ampule used. Episode lasted approximately 1 minute with recovery after 30 minutes. Pt experienced nausea and headache. Resolved spontaneously.
Age: 10.0
Sex: F
Vaccine: HEP, IPV, MMR
Symptoms: Pallor
Clinical narrative: Immediately, post vax, the pt became rigid with her eyes rolled back in her head and loss of consciousness. She was lifted to the floor in RN's lap. Vital signs stable. Circumoral pallor. Ammonia ampule used. Episode lasted approximately 1 minute with recovery after 30 minutes. Pt experienced nausea and headache. Resolved spontaneously.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Infection
Clinical narrative: Subsequent to receiving Varivax, the pt was diagnosed with chicken pox.
Age: 25.0
Sex: F
Vaccine: RUB
Symptoms: Eyelid oedema, Pharyngolaryngeal pain, Pruritus, Swelling face, Urticaria
Clinical narrative: Two hours post vax, the pt began developing hives and itching on arms, chest and hands. Subsequently the pts lips became swollen, left eyelid was swollen and pt experienced a sore throat. There was no shortness of breath. The pt was treated with 2 doses of Benadryl. The hives continued to progress and pt was treated with Atarax every 6 hours and started Medrol dose pak. The pt then saw improvement.
Age: 49.0
Sex: F
Vaccine: TD
Symptoms: Hypoaesthesia, Myalgia, Pain
Clinical narrative: Pt experienced severe arm pain, numbness and muscle soreness.
Age: 1.2
Sex: F
Vaccine: HBHEPB, IPV, MMR
Symptoms: Erythema, Rash papular
Clinical narrative: Five days post vax, the pt developed a fine, papular, red rash on facial area. By seven days post vax, the rash had generalized over entire body area. The pt had no fever, no vomiting and no diarrhea.
Age: 1.25
Sex: F
Vaccine: DT, HIBV
Symptoms: Injection site erythema, Injection site oedema, Oedema peripheral
Clinical narrative: Pt experienced swelling at the injection site, progressing to involve the entire left thigh, left leg and left foot. The pt developed redness around the site of injection.
Age: 18.0
Sex: F
Vaccine: HEP, MMR, VARCEL
Symptoms: Ear disorder, Injection site erythema, Injection site induration, Injection site warmth, Migraine
Clinical narrative: This patient had a 3 inch diameter, red hard, warm, area on her left arm, a fever, migraine with sensitivity to light and sound, left arm pain, wrist and elbow pain, with movement over 1/2/ inch.
Age: 18.0
Sex: F
Vaccine: HEP, MMR, VARCEL
Symptoms: Pain, Photophobia, Pyrexia
Clinical narrative: This patient had a 3 inch diameter, red hard, warm, area on her left arm, a fever, migraine with sensitivity to light and sound, left arm pain, wrist and elbow pain, with movement over 1/2/ inch.
Age: 35.0
Sex: M
Vaccine: HEP, TYP, YF, HEP, TYP, YF
Symptoms: Angioneurotic oedema, Chest discomfort, Face oedema
Clinical narrative: This patient has angioedema, lip swelling, and chest tightness.
Age: 35.0
Sex: M
Vaccine: HEP, TYP, YF, HEP, TYP, YF
Symptoms: Dyspnoea, Periorbital oedema, Urticaria, Wheezing
Clinical narrative: This patient has angioedema, lip swelling, and chest tightness.
Age: 1.3
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Convulsion
Clinical narrative: This patient had a generalized seizure lasting one minute. The was taken to the ER at night. The patient had  received DTAP, HIB vaccine during the during the day.
Age: 5.0
Sex: M
Vaccine: IPV, MMR
Symptoms: Difficulty in walking, Lethargy, Somnolence
Clinical narrative: The day of the vaccine the patient was very lethargic and couldn't walk. The next day he couldn't wake until evening time.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: There was a large area of redness and induration that is areolar on left anterior thigh where one received DPT.
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema
Clinical narrative: This patient had redness at the site of injection.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: This patient developed a diffuse rash over his body, varicella like. He required symptomatic treatment.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: This patient developed diffuse rash (varicella) all over her body. She required symptomatic treatment.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: This patient developed diffuse rash, varicella like. She required symptomatic treatment.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Skin irritation
Clinical narrative: This patient has local redness and irritation at the injection site.
Age: 35.0
Sex: F
Vaccine: HEP
Symptoms: Infection, Influenza, Pyrexia
Clinical narrative: This patient was given vaccine 24 hrs ago. She took a nap this afternoon, woke with a 102 temperature (2:00 PM). On 01/18/01, the PMD reported positive Influenza A culture. The patients temperature went to 104 she saw the PMD, who felt the incident was coincidental that the patient had the flu.
Age: 0.7
Sex: F
Vaccine: DTAP
Symptoms: Agitation, Pyrexia, Stupor, Vomiting
Clinical narrative: This patient had a temperature, after given Tylenol temp was 104.3. She was Hyporesponsive, inconsolably crying, and vomiting, it started at midnight on 01/13/01. The temperature stated before was in the ER at 2PM on 01/13/01. The mother reports the temperature was higher at home. Treatment included 2 baths, Tylenol at home with no response and a mineral bath in the ER.
Age: 2.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site erythema, Injection site induration, Irritability, Pyrexia, Rash macular
Clinical narrative: This child received the Varicella vaccine on 01/05/01. The mother noticed redness at the injection site beginning 01/10/01. The reddened area has increased and is now 5 cm in diameter. The child became fussy, and irritable, low grade fever, area of redness, is slightly firm with macular rash covering reddened area, also non tender. On 01/19/01, the patient is improving.
Age: 0.5
Sex: F
Vaccine: DTAP, HEP, HIBV
Symptoms: Hypotonia
Clinical narrative: This infant has hypotonia spells four times the day following the immunization.
Age: 17.0
Sex: F
Vaccine: HEP, HEP
Symptoms: Abnormal behaviour, Asthenia, Dizziness, Dyspnoea, Heart rate increased
Clinical narrative: This patient had behavior changes, difficulty breathing, hives all over her legs, arms, and chest for a short period, paleness, weakness, very tired, dizziness occasionally, and fast heart beat. The doctor prescribed Beta Blockers, thinking it was an overactive thyroid.
Age: 17.0
Sex: F
Vaccine: HEP, HEP
Symptoms: Pallor, Thyroid disorder, Urticaria
Clinical narrative: This patient had behavior changes, difficulty breathing, hives all over her legs, arms, and chest for a short period, paleness, weakness, very tired, dizziness occasionally, and fast heart beat. The doctor prescribed Beta Blockers, thinking it was an overactive thyroid.
Age: 17.0
Sex: F
Vaccine: HEP, HEP
Symptoms: Abnormal behaviour, Asthenia, Dyspnoea, Heart rate increased, Infection
Clinical narrative: This patient had behavior changes, difficulty breathing, hives all over her legs, arms, and chest for a short period, paleness, weakness, very tired, dizziness occasionally, and fast heart beat. The doctor prescribed Beta Blockers, thinking it was an overactive thyroid.
Age: 17.0
Sex: F
Vaccine: HEP, HEP
Symptoms: Pallor, Urticaria
Clinical narrative: This patient had behavior changes, difficulty breathing, hives all over her legs, arms, and chest for a short period, paleness, weakness, very tired, dizziness occasionally, and fast heart beat. The doctor prescribed Beta Blockers, thinking it was an overactive thyroid.
Age: 7.0
Sex: F
Vaccine: HIBV
Symptoms: Injection site hypersensitivity, Urticaria, Vasodilatation
Clinical narrative: Hives. A mother reported that her 7-year-old daughter received her 4th dose of Hib-Titer on 12/04/1997 and, within hours, developed a 6-inch hive at the injection site. The pt reportedly, subsequently within 6 hours, she developed hives which "migrated over entire body." It was reported that hives covered 80% of bilateral lower extremities, trunk, arms, face and neck. The pt was taken to the ER. Manufacturer's comment: The lot number was reported as M330PD: however this is not a valid Lederle lot number. Follow-up information states that the child developed a large area of erythema surrounding the injection site. Her cheeks were very red and she had a 10-15cm area of erythema on right thigh. She recovered after 24 hours.
Age: 1.25
Sex: U
Vaccine: DTAP, HIBV, PNC, VARCEL
Symptoms: Injection site erythema, Injection site mass, Injection site warmth
Clinical narrative: An MA reported that a 15 month old child received Acel-Imune, Prevnar, Hib and Varivax vaccines on 5/17/00 and within 24 to 48 hours, post vax, the child developed an injection site reaction characterized by a red, warm and hard welt at the site of the Acel-Imune administration. This is 1 of 6 pts from this facility who experienced this event following receipt of 3 different lots of Acel-Imune.
Age: 12.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Hypersensitivity, Nuclear magnetic resonance imaging brain abnormal, Skin papilloma
Clinical narrative: The mother of a 12 year old female reported that her daughter inadvertently received DTaP or DT and MMR vaccines on 12/16/98. A couple of weeks post vax, she experienced a hypersensitivity allergic reaction with DTaP or DT manifested by "warts on the back of her left ankle". The mother indicated that the pt was treated with every prescription medication including fungus medications an OTC wart medications, however the warts persisted. In March 1993 the pt experienced neurotic eye movements, dizzy spells, croup cough, vomiting and Bell's Palsy. In December 1999 a MRI showed "white matter lesions". A second MRI also showed "white matter lesions". The pt has been seen in the ER several times. She was treated with PCN orally and experienced an allergic reaction. The pt was taken to a children's ER and to counteract the allergic reaction.
Age: 1.75
Sex: M
Vaccine: DTAP, IPV, PNC
Symptoms: Disorientation, Pain, Pyrexia
Clinical narrative: A pharmacy employee reported that on 7/20/00 the patient developed a high fever, disorientation and pain. He recovered. This is 1 of 3 patients from this facility who had an adverse experience following receipt of Acel-Imune lot 469-396 or the concomitantly administered vaccines. A copy of this report was forwarded to Aventis Pasteur, manufacturer of IPOL.
Age: 10.0
Sex: F
Vaccine: HEP, HIBV, TD
Symptoms: Vomiting
Clinical narrative: Vomiting. A nurse reported that a 10-year-old female inadvertently received 2 injections of Hib-Titer, one in each arm on 08/09/2000. She also received diphtheria and tetanus toxoids and hepatitis B vaxs. The following day she developed vomiting. Follow up states patient recovered.
Age: 66.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Pyrexia
Clinical narrative: The pt experienced an elevated temp of 102.4 and a very sore arm. The pt took 2 325mg aspirin.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV
Symptoms: Cardiac arrest, Coma, Cyanosis
Clinical narrative: Pt found in crib unresponsive and cyanotic baby. CPR started by EMS and transported to local hospital. Pt stayed in asystole even after 3 epi doses and 2 atropine CPR. Pronounced DOA at ER and medical examiners office notified and body transferred.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Contusion, Laboratory test abnormal, Thrombocytopenic purpura
Clinical narrative: The mother described the pt having thrombocytopenia purpura following vaccination. He had a 2x2 inch purple bruise on the back of his right arm. The parents discussed this and decided a blood vessel must have been hit when the vaccine was given. After school started they began noticing more bruises. For awhile they attributed it to being a 4 year old and new playground equipment rough housing. The he started to get bruises in odd places like the stomach, face, and upper legs. We discussed this with preschool and daycare. After 2 months we decided to have a blood test done at our family doctor. The results were platelets 7,000. They were sent to another facility and once they were there the lab results were platelets - 2,000. We then had Win Rho administered. Since then we have had 9 more blood tests with up and down results. Per annual follow up last platelet was 22,000 in march 2002. Patient still bruises easily + cannot participate in the usually. activities(sports); telephone interview with mother.  Annual follow up 10/29/2003: "Vaccine recipient did not recover from the adverse events. 07/09/2003: Platelet count 76,000; normal value 150-400,000."
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain, Confusional state, Constipation, Dizziness, Impaired gastric emptying
Clinical narrative: On 9/12/00, had migraine headache, swollen glands, dizzy, nausea, constipation, lethargy, confusion, vomiting, obsessive behavior and abdominal pain. Treated with migranol, Reglan, Zyrtec, Rhinocort, Prilosec, Agoral. 60 day follow-up states the pt still has viral gastroparesis.
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Lethargy, Lymphadenopathy, Migraine, Nausea, Obsessive-compulsive disorder
Clinical narrative: On 9/12/00, had migraine headache, swollen glands, dizzy, nausea, constipation, lethargy, confusion, vomiting, obsessive behavior and abdominal pain. Treated with migranol, Reglan, Zyrtec, Rhinocort, Prilosec, Agoral. 60 day follow-up states the pt still has viral gastroparesis.
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Vomiting
Clinical narrative: On 9/12/00, had migraine headache, swollen glands, dizzy, nausea, constipation, lethargy, confusion, vomiting, obsessive behavior and abdominal pain. Treated with migranol, Reglan, Zyrtec, Rhinocort, Prilosec, Agoral. 60 day follow-up states the pt still has viral gastroparesis.